APP and Alzheimer disease: One of the primary bioactive components, tetrahydroxystilbene-2-O-glycoside from Radix Polygoni multiflori, decreases APP expression and enhances cognitive activity in transgenic mice with AD by reducing Beclin-1 and LC3-II expression through autophagy [103].